Hematology CME

The 2nd Annual Cleveland Clinic Cancer Conference features the latest advances in the diagnosis and management of the most prevalent cancers at all stages of disease and treatment. A world-renowned faculty provide disease specific, evidence-based, practical presentations representing a variety of medical disciplines. This includes current and future strategies for cancer care, while detailing the role of emerging technologies, support and non-pharmacologic therapeutics for the cancer patient.

On-the-go Audio CME: Learn from the Experts

With its comprehensive coverage of all 16 ACP MKSAP topic areas, our all-new ACP MKSAP^SM Audio Companion keeps you engaged with fascinating discussions led by renowned contributors and section editors, breaking down the latest advances in a format designed for active listening.

Stay on top of your game with the StatPearls Physician Unlimited CME programs. With 6,046 activities, StatPearls is the largest CME provider in the world. These Pub-Med Indexed articles are categorized into 162 specialty areas which lets you better access activities that will make the biggest impact on your practice. One subscription allows access to all the activities, including all state-requirements.

Pricing Options

• 6 Month subscription: All 6,339 CME Activities – $249 per 6 months
• Annual subscription: All 6,339 CME Activities – $349 per 1 year
• Lifetime: All 6,339 CME Activities + Access to Board Reviews Forever – $1999

Essential Hematology and Oncology CMEThe Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology is a case-based online video CME program focused on improving overall knowledge and clinical competency with comprehensive updates on basic principles, changing guidelines, and therapeutic strategies. Continuing medical education areas for practice improvement include:

• Hematopoiesis and Cytokines
• Platelet Disorders
• Molecular Basis of Cancer
• New Therapies (Pharmacology)
• Palliative Care (Management of Symptoms/End of Life)
• Gastrointestinal Cancers (Neuroendocrine/Esophageal/Pancreas/Colorectal)
• Thoracic Oncology (Head/Neck/Lung/Thyroid)
• and many more…

Medical videos & lectures explained clearly by world-class instructors.

Memorable illustrations, clinical scenarios, and passionate instructors set MedCram apart from other online medical lectures.

We prioritize the most important clinically relevant and practical information for clinical practice.

Understanding medicine has never been so simplified.

Brilliant Courses’ Internal Medicine Board Review is a high-yield, evidence-based program crafted for busy clinicians aiming to refresh their knowledge, deepen their clinical reasoning, and stay current with evolving medical standards.

Whether you’re preparing for board certification or seeking real-world clinical insights, this all-in-one bundle delivers a comprehensive learning experience across the full spectrum of adult medicine.

Now Includes: On-Demand Internal Medicine Updates and Refresher Course

20.25 AMA PRA Category 1 Credit(s)™ and up to 20.25 ABIM MOC Points

Available: October 1, 2025 – October 1, 2027

High-yield updates in internal medicine and key specialties, with practical, evidence-based learning designed for internists, hospitalists, primary care specialists, PAs, NPs, nurses, residents, and subspecialists.

The BoardVitals Hematology and Oncology CME Review offers clinicians 27 AMA PRA Category 1 Credits^TM, 27 ABIM MOC points, and over 500 Hematology and Oncology board review questions. The questions cover key topics including Breast Cancer, Gynecologic Cancer, and Transfusion Medicine. This question bank will assist clinicians with Hematology and Oncology certification and recertification.

The BoardVitals Hematology and Oncology CME Review also features:

• Quick and Convenient CME
• Computer, phone, and tablet access
• Constantly updated up-to-date questions
• Questions that are targeted specifically to the exam
• Online CME tracker
• 100% Pass Guarantee
• Statistical comparison to other Hematology and Oncology test-takers (Nationally)

After completing this activity, you should be able to:

• Make a diagnosis
• Order and interpret results
• Assess risk, determine prognosis, and apply principles from epidemiologic studies
• Describe the underlying pathophysiology of disease and basic science knowledge

Target Audience: Hematologists and Oncologists

Updates in Primary Immunodeficiency provides an educational forum for in-depth reviews of common and rare inborn errors of immunity (IEI). Cleveland Clinic’s expert faculty discusses this group of more than 400 complex, chronic disorders, and provides insight on developing diagnostics, therapies and advances in treatment. Healthcare practitioners with an interest in allergy, immunology, rheumatology, hematology and more will all benefit from the didactic lectures and cases presented throughout this comprehensive activity. Worth 10 AMA PRA Category I Credits™ applicable to American Board of Allergy and Immunology Continuing Certification. ANCC and AAPA accreditation provided as well!

A new, comprehensive resource designed to support clinicians across all specialties. Whether you’re treating heart disease, infectious illnesses, or managing preventive care, this collection offers a unique blend of pharmacology updates and lifestyle intervention strategies. With topics ranging from pediatric obesity to hyperbilirubinemia in newborns, and from cell therapy to adult and adolescent vaccinations, Clinical Guidelines & Updates Topical Collection equips you with practical insights that can be applied directly to everyday care.

Unlimited access to all current and new courses for 1 year.

• 60+ Courses
• 1 Year Unlimited Access
• 60+ CME/CE Hours
• New Courses added regularly
• “MedCram Difference” Guarantee
• A $1400 value if each course is purchased individually

Discover a deeper understanding of Sickle Cell Disease through an engaging, expert-led online webinar designed specifically for physicians. This concise yet impactful session features a presentation by a nationally recognized SCD expert who will share the latest insights on diagnosis, management strategies, and emerging approaches to care. Complementing the clinical perspective, a professional patient advocate will offer a powerful personal testimony, providing real-world context on living with the disease its effects on everyday life and navigating a challenging healthcare system. This unique combination of medical expertise and lived experience delivers practical knowledge you can immediately apply in your practice while strengthening patient-centered care. Additionally, you will witness two scenarios portraying a patient interacting with a provider that will offer actionable insights you can use to take patient care to the next level. Join peers in advancing your understanding and making a meaningful difference in the lives of patients with Sickle Cell Disease.

Join PES on a 14-night cruise during the height of Japan’s spring cherry blossom season and discover the beauty of the region, from ancient temples and serene gardens to vibrant cities and modern skyscrapers, while sailing aboard the ultra-luxury, all-inclusive, 596-guest Silversea Silver Moon. This Seminar is planned for 12 Continuing Education Credit Hours

CME/CE Professional Seminar Fee: $695
Seminar Attendance Fee: $450
CME/CE credits, Certificates of Completion and possible tax deductible guidelines will be provided for registered Professional Seminar attendees Certificates of Attendance will be provided for ALL registered seminar participants

Seminar Overview/Statement of Purpose:

Healthcare practitioners are currently faced with the challenges of both treating and preventing the ever-increasing incidence of chronic diseases in the US population. In addition, the need to adapt best practice models in the context of emerging healthcare reforms impacting patient care delivery and access to care is an important issue for all healthcare practitioners to address.

For the last 20 years, Japan has been ranked number one in the world in both life expectancy and healthy lifestyles, but Japan should not be complacent simply because of its high life expectancy. Japan’s healthcare system is fundamentally a system of universal health insurance coverage. Japanese citizens belong to the national health insurance, workplace-based health insurance, or government-managed health insurance system. It is a free-access system with no gatekeepers that allows people to be examined and treated at the medical institutions of their choice, regardless of their symptoms. We explore these challenges with in-country professionals and provide opportunities for practitioners to enhance healthcare delivery models and best practices to prevent and control disease in cross-cultural environments.